GM Advisory Group LLC Sells 1,078 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

GM Advisory Group LLC trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 11.9% in the 4th quarter, HoldingsChannel reports. The fund owned 7,991 shares of the healthcare conglomerate’s stock after selling 1,078 shares during the quarter. GM Advisory Group LLC’s holdings in UnitedHealth Group were worth $4,042,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the stock. State Street Corp raised its position in shares of UnitedHealth Group by 1.3% in the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after acquiring an additional 563,554 shares in the last quarter. Geode Capital Management LLC raised its position in shares of UnitedHealth Group by 1.6% in the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock worth $11,440,133,000 after acquiring an additional 318,039 shares in the last quarter. Franklin Resources Inc. increased its position in UnitedHealth Group by 2.5% during the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock valued at $4,884,019,000 after buying an additional 193,800 shares in the last quarter. Bank of New York Mellon Corp increased its position in UnitedHealth Group by 0.5% during the 4th quarter. Bank of New York Mellon Corp now owns 7,931,478 shares of the healthcare conglomerate’s stock valued at $4,012,218,000 after buying an additional 36,394 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in UnitedHealth Group by 3.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 6,223,331 shares of the healthcare conglomerate’s stock valued at $3,148,134,000 after buying an additional 182,361 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several brokerages recently issued reports on UNH. Wells Fargo & Company reduced their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Truist Financial reduced their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Finally, Oppenheimer raised their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Twenty investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $629.32.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Up 0.9 %

Shares of UNH opened at $503.61 on Wednesday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock’s 50 day moving average is $510.90 and its two-hundred day moving average is $548.54. The firm has a market cap of $460.66 billion, a P/E ratio of 32.49, a PEG ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the company earned $5.83 earnings per share. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.67%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.